Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with neuroprotective properties against β-amyloid-induced toxicity-Reference-Cited by-同舟云学术

Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with neuroprotective properties against β-amyloid-induced toxicity

Published:2005-07 Issue:1 Volume:49 Page:86-96
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Lecanu Laurent,Yao Wenguo,Piechot Alexander,Greeson Janet,Tzalis Dimitrios,Papadopoulos Vassilios

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference51 articles.

1. Chronic corticosterone administration dose-dependently modulates Abeta(1–42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis;Abraham;J Neuroendocrinol,2000

2. Pre-ischaemic administration of procaine suppresses ischaemic glutamate release and reduces neuronal damage in the gerbil hippocampus;Adachi;Br. J. Anaesth,1999

3. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons;Bastianetto;Br. J. Pharmacol,2000

4. The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethylaminoethanol;Brodie;J. Pharmacol. Exp. Ther,1948

5. Improvement of ischemic damage in gerbil hippocampal neurons by procaine;Chen;Brain Res,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased vulnerability of brain to estrogen withdrawal-induced mitochondrial dysfunction with aging;Journal of Bioenergetics and Biomembranes;2008-12

2. Ginsenoside Rg1 attenuates β-amyloid-induced apoptosis in mutant PS1 M146L cells;Neuroscience Letters;2008-10

3. Possible role of mitochondrial dysfunction in central neurodegeneration of ovariectomized rats;Cell Biochemistry and Function;2008

4. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics;Journal of Neurochemistry;2006-06